- Home
- POWW vs APLT Comparison
POWW vs APLT Comparison
Compare POWW & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POWW
- APLT
- Stock Information
- Founded
- POWW 1990
- APLT 2016
- Country
- POWW United States
- APLT United States
- Employees
- POWW N/A
- APLT N/A
- Industry
- POWW Ordnance And Accessories
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- POWW Industrials
- APLT Health Care
- Exchange
- POWW Nasdaq
- APLT Nasdaq
- Market Cap
- POWW 167.5M
- APLT 178.6M
- IPO Year
- POWW N/A
- APLT 2019
- Fundamental
- Price
- POWW $1.53
- APLT $1.39
- Analyst Decision
- POWW Strong Buy
- APLT Buy
- Analyst Count
- POWW 1
- APLT 5
- Target Price
- POWW $2.00
- APLT $4.13
- AVG Volume (30 Days)
- POWW 463.7K
- APLT 13.0M
- Earning Date
- POWW 11-10-2025
- APLT 11-06-2025
- Dividend Yield
- POWW N/A
- APLT N/A
- EPS Growth
- POWW N/A
- APLT N/A
- EPS
- POWW N/A
- APLT N/A
- Revenue
- POWW $44,004,480.00
- APLT $121,000.00
- Revenue This Year
- POWW $10.08
- APLT N/A
- Revenue Next Year
- POWW $0.94
- APLT $5,935.35
- P/E Ratio
- POWW N/A
- APLT N/A
- Revenue Growth
- POWW 62.90
- APLT N/A
- 52 Week Low
- POWW $0.95
- APLT $0.30
- 52 Week High
- POWW $2.14
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- POWW 54.91
- APLT 68.30
- Support Level
- POWW $1.42
- APLT $0.90
- Resistance Level
- POWW $1.58
- APLT $1.50
- Average True Range (ATR)
- POWW 0.07
- APLT 0.16
- MACD
- POWW -0.00
- APLT 0.03
- Stochastic Oscillator
- POWW 52.48
- APLT 81.57
About POWW AMMO Inc.
Outdoor Holding Co Formerly AMMO Inc is the owner of GunBroker.com, the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketing of ammunition and ammunition component products and the marketplace segment consists of the GunBroker.com marketplace. The company generates the majority of its revenue from the Ammunition segment.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.